UPDATE : Saturday, February 22, 2020
상단여백
Fenbendazole craze expands to human parasiticide by Lee Han-soo 2020-01-07 12:33
Eliquis price cut delayed amid prolonged administrative suit by Kim Yun-mi 2020-01-07 11:32
Chinese drugmaker Mebo establishes branch in Korea by Lee Han-soo 2020-01-06 14:40
[New Year Special] Boryung, Hanmi in fierce battle to fill ranitidine void by Jeong Sae-im 2020-01-03 17:56
Bukwang, Sanofi Aventis Korea to co-promote hypertension med by Lee Han-soo 2020-01-03 17:55
라인
Daewoong launches oral typhoid fever vaccine by Lee Han-soo 2020-01-03 17:55
[New Year Special] Rise of digital therapeutics to change healthcare scene for good by Lee Han-soo 2020-01-03 14:57
SK Bioscience’s influenza vaccine nabs WHO certification by Lee Han-soo 2020-01-03 14:14
Daewoong to kick off P3 trial of Nabota in China by Lee Han-soo 2020-01-02 17:36
FDA OKs Huons' generic of topic anesthetic injection by Lee Han-soo 2020-01-02 14:30
라인
Medytox launches liquid-type BTX 'Innotox 100 unit' in local market by Lee Han-soo 2020-01-02 12:12
Korean biopharmaceuticals competitively move abroad to expand global presence by Jeong Sae-im 2019-12-30 17:20
Migraine drug market heats up with Ubrelvy’s arrival by Kim Yun-mi 2019-12-27 11:57
Local biopharmaceutical companies suffer from unsatisfactory P3 global trial results by Jeong Sae-im 2019-12-27 07:06
Dupixent to get coverage from January by Kim Yun-mi 2019-12-24 15:40
라인
‘Korea still slow to expand benefit for new drugs’ by Kim Yun-mi 2019-12-24 15:37
Shanghai Ocumension to market Huonland's HA eyedrop by Lee Han-soo 2019-12-23 15:43
Alteogen's growth hormone deficiency treatment wins orphan drug status by Lee Han-soo 2019-12-23 14:46
Daewoong partners with Aeon Biopharma to tap therapeutic BTX market by Lee Han-soo 2019-12-23 11:23
Successful drug development – getting it right from the start by Lee Han-soo 2019-12-20 16:30
여백
여백
여백
Back to Top